KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biocryst Pharmaceuticals (BCRX) Interest Expenses: 2011-2014

Historic Interest Expenses for Biocryst Pharmaceuticals (BCRX) over the last 4 years, with Dec 2014 value amounting to $5.0 million.

  • Biocryst Pharmaceuticals' Interest Expenses rose 1.97% to $1.2 million in Q3 2015 from the same period last year, while for Sep 2015 it was $5.2 million, marking a year-over-year increase of 5.08%. This contributed to the annual value of $5.0 million for FY2014, which is 4.60% up from last year.
  • Per Biocryst Pharmaceuticals' latest filing, its Interest Expenses stood at $5.0 million for FY2014, which was up 4.60% from $4.8 million recorded in FY2013.
  • In the past 5 years, Biocryst Pharmaceuticals' Interest Expenses ranged from a high of $5.0 million in FY2014 and a low of $3.8 million during FY2011.
  • In the last 3 years, Biocryst Pharmaceuticals' Interest Expenses had a median value of $4.8 million in 2013 and averaged $4.8 million.
  • Data for Biocryst Pharmaceuticals' Interest Expenses shows a peak YoY increased of 23.64% (in 2012) over the last 5 years.
  • Yearly analysis of 4 years shows Biocryst Pharmaceuticals' Interest Expenses stood at $3.8 million in 2011, then climbed by 23.64% to $4.7 million in 2012, then increased by 2.40% to $4.8 million in 2013, then increased by 4.60% to $5.0 million in 2014.